Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • ResearchNews

WHO Study Identifies Key Endemic Pathogens in Urgent Need of New Vaccines

  • The Pharma Data
  • November 5, 2024

A recent World Health Organization (WHO) study, published in eBioMedicine, has identified 17 priority pathogens that are endemic in various communities and urgently require new vaccines. This marks WHO’s first…

Read MoreWHO Study Identifies Key Endemic Pathogens in Urgent Need of New Vaccines
  • RegulatoryNews

Libra Therapeutics Names Dr. Shawn A. Scranton as President and CEO

  • The Pharma Data
  • November 2, 2024

Libra Therapeutics, Inc., a private biotechnology company focused on developing innovative therapies to restore cellular balance and reduce neurodegeneration, has announced the appointment of Shawn A. Scranton, PharmD, as President…

Read MoreLibra Therapeutics Names Dr. Shawn A. Scranton as President and CEO
  • Research

Kashiv BioSciences Names Dr. Sandeep Nilkanth Athalye as Global CEO

  • The Pharma Data
  • November 2, 2024

Kashiv BioSciences, LLC, a globally integrated biopharmaceutical company, has appointed Dr. Sandeep Nilkanth Athalye as its new Global Chief Executive Officer. With over 20 years of experience in strategic and…

Read MoreKashiv BioSciences Names Dr. Sandeep Nilkanth Athalye as Global CEO
  • Research

Medidata and Cogstate Partner to Enhance Neurology Clinical Trials with AI Solutions

  • The Pharma Data
  • November 2, 2024

Medidata, a brand of Dassault Systèmes and a leading provider of clinical trial solutions, has partnered with Cogstate, a leader in neuroscience solutions, to transform clinical trials and outcome measurements…

Read MoreMedidata and Cogstate Partner to Enhance Neurology Clinical Trials with AI Solutions
  • Business

Vir Biotechnology Releases Q3 2024 Financial Results and Corporate Update

  • The Pharma Data
  • November 2, 2024

Vir Biotechnology, Inc. (Nasdaq: VIR) has released its corporate update and financial results for the third quarter ended September 30, 2024. “This quarter marked a transformative period for Vir. We…

Read MoreVir Biotechnology Releases Q3 2024 Financial Results and Corporate Update
  • Press Releases

Lilly to Present Phase 3 EMBER-3 Study Results for Imlunestrant at San Antonio Breast Cancer Symposium

  • The Pharma Data
  • November 2, 2024

Eli Lilly and Company (NYSE: LLY) has announced that data from the Phase 3 EMBER-3 trial of imlunestrant, an oral selective estrogen receptor degrader (SERD), will be presented for the…

Read MoreLilly to Present Phase 3 EMBER-3 Study Results for Imlunestrant at San Antonio Breast Cancer Symposium
  • NewsPress Releases

Ma Xin, Jiangsu Vice Governor, Visits Hansoh Pharma Subsidiary

  • The Pharma Data
  • November 2, 2024

On the morning of October 30, Ma Xin, a member of the Standing Committee of the Jiangsu Provincial Party Committee and Executive Vice Governor, visited Jiangsu Hansoh, a subsidiary of…

Read MoreMa Xin, Jiangsu Vice Governor, Visits Hansoh Pharma Subsidiary
  • News

ASN 2024 | Hansoh Pharma Shares Post-Hoc Results from Phase III Pegmolesatide Study

  • The Pharma Data
  • November 2, 2024

The 2024 American Society of Nephrology (ASN) Kidney Week conference took place at the San Diego Convention Center from October 23 to 27. During this event, a post-hoc analysis of…

Read MoreASN 2024 | Hansoh Pharma Shares Post-Hoc Results from Phase III Pegmolesatide Study
  • Press Releases

Teva Unveils New Schizophrenia Research: Positive Phase 3 TEV-‘749 and UZEDY® Data

  • The Pharma Data
  • November 2, 2024

Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has announced encouraging new data from the Phase 3 SOLARIS trial on TEV-‘749, a subcutaneous extended-release…

Read MoreTeva Unveils New Schizophrenia Research: Positive Phase 3 TEV-‘749 and UZEDY® Data
  • Press Releases

Teva Presents New TD Data at Psych Congress 2024, Highlighting Patient Differences

  • The Pharma Data
  • November 2, 2024

Teva Pharmaceuticals, the U.S. branch of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has released interim findings from its Phase 4 IMPACT-TD Registry study. This large-scale study sheds light…

Read MoreTeva Presents New TD Data at Psych Congress 2024, Highlighting Patient Differences
  • News

New WHO Report Highlights Urban Efforts in Preventing NCDs and Injuries

  • The Pharma Data
  • November 1, 2024

On World Cities Day, the World Health Organization (WHO) launched a new report highlighting how urban areas can tackle the increasing challenges posed by noncommunicable diseases (NCDs) and injuries. As…

Read MoreNew WHO Report Highlights Urban Efforts in Preventing NCDs and Injuries
  • News

Uganda and WHO Launch Strategies to Enhance Healthcare for Refugees and Migrants

  • The Pharma Data
  • November 1, 2024

A new report titled “Refugee and Migrant Health System Review: Challenges and Opportunities for Long-Term Health System Strengthening in Uganda” was launched on October 15 by Uganda’s Ministry of Health…

Read MoreUganda and WHO Launch Strategies to Enhance Healthcare for Refugees and Migrants
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Ono Pharma Files Approval Application in Japan for Ripretinib in Advanced Gastrointestinal Stromal Tumor
  • Neurocrine Biosciences Unveils First Expert Consensus Guidelines for Tardive Dyskinesia in Long-Term Care Settings
  • Allergan Aesthetics Introduces Next-Generation JUVÉDERM Hyaluronic Acid Injectables at AMWC Monaco
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.